Latest / The Well-Built Life / Battling Long COVID: The Virus, the Cells, and the Cure
Transcript
- 0:00Speaker 1: Hey everyone, welcome back to The Well-Built Life. I am
- 0:03Speaker 1: Rachel Caldwell, alongside Thomas Bennett, and we are so glad
- 0:07Speaker 1: you are tuning in. We are here to cut through
- 0:09Speaker 1: the noise, skip the intense jargon and extreme rules, and
- 0:13Speaker 1: share simple practical habits that help you feel stronger, healthier,
- 0:18Speaker 1: and more balanced every single day. Grab a drink, get comfortable,
- 0:23Speaker 1: and let's dive in. Okay, Thomas. Let's dive into the
- 0:26Speaker 1: fascinating and complex world of long COVID and chronic fatigue syndrome.
- 0:31Speaker 1: It's amazing how these conditions seem so similar, yet, are
- 0:35Speaker 1: rooted in such intricate interplays of the immune system. Thomas,
- 0:39Speaker 1: have you been following the research on Epstein-Barr virus and
- 0:42Speaker 1: its connection to these syndromes?
- 0:44Speaker 2: Absolutely, Rachel. Epstein-Barr virus, EBV, has been a central player
- 0:49Speaker 2: in this narrative. It's interesting how a virus that's typically
- 0:52Speaker 2: thought of as just causing mild mononucleosis can have such
- 0:56Speaker 2: profound long-term effects on the immune system. Let's start with
- 0:59Speaker 2: a simple question. How does EBV typically establish latency in
- 1:04Speaker 2: the body?
- 1:04Speaker 1: Ah, good point. EBV can hang around in a dormant
- 1:08Speaker 1: state for years, hidden in the cells of the immune system,
- 1:11Speaker 1: particularly in the tonsils and lymph nodes. It's like a
- 1:15Speaker 1: sleeper agent, ready to reactivate under certain conditions. What are
- 1:20Speaker 1: some of these triggers that Thomas.
- 1:22Speaker 2: Well, stress is a key factor. Research from 2016 identified
- 1:26Speaker 2: surgical procedures and the use of prednisone as potent triggers
- 1:31Speaker 2: for EBV reactivation. Grief, divorce, job loss, poor sleep, alcohol consumption...
- 1:38Speaker 2: And overtraining can all push the immune system to a
- 1:40Speaker 2: breaking point, allowing EBV to start disrupting its normal functions.
- 1:45Speaker 1: That's a lot to unpack. So, how do natural killer
- 1:48Speaker 1: NK cells factor into all of this? NK cells are
- 1:53Speaker 1: supposed to be the front line of defense against viruses
- 1:55Speaker 1: like EBV, right?
- 1:57Speaker 2: Exactly. NK cells are the silent warriors of the immune system.
- 2:01Speaker 2: They are supposed to seek out and destroy virally infected cells,
- 2:05Speaker 2: but when NK cell function is hampered by chronic stress
- 2:08Speaker 2: or EBV reactivation, it disrupts the delicate balance of the
- 2:11Speaker 2: immune response. This leads to prolonged exhaustion, inflammation, and cognitive fog,
- 2:18Speaker 2: which are hallmark symptoms of both long COVID and chronic
- 2:21Speaker 2: fatigue syndrome.
- 2:22Speaker 1: Makes sense. So, let's talk about B vitamins, particularly thiamine, B1.
- 2:28Speaker 1: The research from 2019 to 2021H has shown that deficiencies
- 2:34Speaker 1: in B1 can be a contributing factor to exacerbating these symptoms.
- 2:38Speaker 1: How does B1 deficiency affect the autonomic nervous system, and
- 2:43Speaker 1: why is it such a critical player in managing these conditions?
- 2:47Speaker 2: B1 is essential for metabolism and for the proper function
- 2:51Speaker 2: of the autonomic nervous system. When the immune response is heightened,
- 2:55Speaker 2: it can lead to chronic inflammation. which depletes B1. This
- 2:59Speaker 2: further exacerbates the symptoms, creating a vicious cycle. Supplementing with
- 3:04Speaker 2: a lithiumine, along with cofactors B2, B3, and magnesium, can
- 3:10Speaker 2: help support the natural regenerative processes, but it's just one
- 3:14Speaker 2: piece of the puzzle.
- 3:15Speaker 1: True, and it's fascinating how the interaction between EBV, NK
- 3:19Speaker 1: cell dysfunction, and B1 deficiency creates such complex and interconnected issues. Thomas,
- 3:28Speaker 1: Can we talk about some of the management strategies that
- 3:31Speaker 1: have been developed to address this?
- 3:33Speaker 2: Certainly. Low-dose naltrexone, cold therapy, specific breathing exercises, intermittent fasting,
- 3:40Speaker 2: and targeted nutritional interventions like thiamine, coenzyme Q10, NIDHD, ribose, zinc,
- 3:48Speaker 2: and vitamin D have shown promise. It's a balanced approach
- 3:52Speaker 2: combining both pharmaceutical and natural methods to address the underlying issues.
- 3:57Speaker 1: And what about the challenges and contradictions that come with
- 4:00Speaker 1: these management strategies? Like the debate over increasing physical activity
- 4:05Speaker 1: and the necessity of addressing autonomic nervous system dysregulation.
- 4:10Speaker 2: Right, that's a critical point. While exercise can be beneficial
- 4:14Speaker 2: in most cases, overtraining can actually reactivate latent viruses and
- 4:19Speaker 2: worsen symptoms. It's a delicate balance, which is why personalized
- 4:23Speaker 2: treatment plans are so important. The challenge lies in ensuring
- 4:27Speaker 2: that each individual receives the right combination of treatments tailored
- 4:30Speaker 2: to their specific needs.
- 4:32Speaker 1: And looking ahead, what do you think the future holds
- 4:35Speaker 1: for treating long COVID and chronic fatigue syndrome? How could
- 4:39Speaker 1: advances in understanding viral latency and immune system regulation impact
- 4:45Speaker 1: how we approach these conditions?
- 4:47Speaker 2: I believe that as our understanding improves, we will see
- 4:50Speaker 2: more targeted therapies emerge. The long-term effects of chronic low-dose
- 4:55Speaker 2: naltrexone and the interplay of B vitamins and cofactors in
- 4:59Speaker 2: managing these conditions are key areas of ongoing research. Personalized
- 5:04Speaker 2: medicine using genetic and epigenetic markers could pave the way
- 5:08Speaker 2: for more precise treatment protocols.
- 5:11Speaker 1: Okay, so let's dive into the reactivation of the Epstein-Barr
- 5:14Speaker 1: virus and the breakdown of natural killer cells. Thomas. Can
- 5:19Speaker 1: you walk us through when scientists first started piecing this together?
- 5:23Speaker 2: Sure, Rachel. The story begins in the mid-2010s when researchers
- 5:28Speaker 2: started noticing these long, hall symptoms in patients recovering from SARS,
- 5:34Speaker 2: COVAV-2 infections. By 2015, we started seeing more studies linking
- 5:39Speaker 2: chronic fatigue syndrome with Epstein-Barr virus. The concept of a
- 5:43Speaker 2: doorbell alarm mechanism, proposed around 2016, really brought clarity to
- 5:48Speaker 2: why natural killer cells become dysfunctional.
- 5:51Speaker 1: Right, and that's the crucial nuance here. That natural killer
- 5:55Speaker 1: cells are supposed to be part of the first line
- 5:57Speaker 1: of defense against viruses, like EBV. But under stress, they
- 6:02Speaker 1: seem to fall short. Can you dive deeper into the
- 6:05Speaker 1: stressors that can trigger this breakdown?
- 6:07Speaker 2: Absolutely. The list of stressors is quite comprehensive. Surgery, particularly hysterectomies,
- 6:14Speaker 2: have been linked with EBV reactivation, Synthetic corticosteroids like prednisone
- 6:20Speaker 2: also suppress the immune system, potentially leading to reactivation. Bereavement
- 6:24Speaker 2: can cause up to six months of immune suppression, and
- 6:28Speaker 2: even something as simple as overexercise can overwork your body,
- 6:32Speaker 2: making it more susceptible. Grief, divorce, job loss, poor sleep, alcohol,
- 6:38Speaker 2: and overexercise are all potent triggers.
- 6:40Speaker 1: That's wild when you look at the raw numbers. So,
- 6:44Speaker 1: it's not just physical trauma causing this, but psychological factors
- 6:47Speaker 1: as well. How do these stressors actually affect the breakdown
- 6:52Speaker 1: of natural killer cells?
- 6:53Speaker 2: It's a deep dive, but basically stressors like bereavement, poor sleep,
- 6:57Speaker 2: and alcohol can suppress the immune system, making natural killer
- 7:01Speaker 2: cells less effective. Chronic inflammation from these stressors can lead
- 7:05Speaker 2: to a state of prolonged exhaustion and autoimmune reactions. The
- 7:09Speaker 2: autonomic nervous system which is crucial for regulating these processes,
- 7:14Speaker 2: gets thrown out of whack, leading to an even greater
- 7:17Speaker 2: depletion of B1, which is vital for glucose metabolism and
- 7:21Speaker 2: the autonomic nervous system.
- 7:23Speaker 1: That's a fascinating cycle. So, when we are dealing with
- 7:27Speaker 1: conditions like long COVID and chronic fatigue syndrome, we are
- 7:31Speaker 1: looking at a complex interplay between physical and mental stress.
- 7:35Speaker 1: Does this also mean that managing these conditions goes beyond
- 7:39Speaker 1: just addressing the virus?
- 7:40Speaker 2: Absolutely. It's about addressing the root causes of immune dysfunction.
- 7:45Speaker 2: That's why we see a heavy emphasis on B1 supplementation,
- 7:49Speaker 2: along with low-dose naltrexone, which can help modulate the immune system.
- 7:53Speaker 2: Other strategies like cold therapy, specific breathing exercises, and intermittent
- 7:58Speaker 2: fasting can also support the body's natural healing mechanisms.
- 8:02Speaker 1: It's amazing how multifaceted this all is. And it's not
- 8:06Speaker 1: just about the B1 either. The interplay of other B
- 8:09Speaker 1: vitamins and cofactors, like coenzyme Q10 and D, ribose is crucial.
- 8:16Speaker 1: How do these specifically support the immune system?
- 8:19Speaker 2: Great question, Rachel. B1, also known as thiamine, plays a
- 8:23Speaker 2: key role in maintaining metabolic processes and supporting the autonomic
- 8:27Speaker 2: nervous system. Coenzyme Q10 is essential for cellular energy production.
- 8:32Speaker 2: and D-ribose supports ATP synthesis, which is fundamental for cellular energy.
- 8:37Speaker 2: All of these work synergistically, essentially providing the building blocks
- 8:41Speaker 2: the body needs to recover.
- 8:43Speaker 1: That's a powerful combination, and it's interesting to see how
- 8:46Speaker 1: these interventions are becoming more personalized. Are we moving towards
- 8:51Speaker 1: a future where genetic and epigenetic markers play a significant
- 8:55Speaker 1: role in treatment protocols?
- 8:57Speaker 2: Definitely. The future is looking at more personalized medicine. where
- 9:01Speaker 2: genetic and epigenetic profiles can guide the most effective treatment strategies.
- 9:06Speaker 2: This approach acknowledges the individual variability in response to therapies
- 9:10Speaker 2: and can significantly improve outcomes. As we continue to unravel
- 9:14Speaker 2: the mechanisms, we are getting closer to more precise and
- 9:18Speaker 2: targeted therapies.
- 9:19Speaker 1: It's incredibly encouraging to see such personalized approaches. So, in summary,
- 9:24Speaker 1: we are facing a complex challenge. But with a growing
- 9:28Speaker 1: understanding of the mechanisms... we are moving towards more effective
- 9:32Speaker 1: and holistic treatments. That's the exciting part, isn't it? So, Thomas,
- 9:37Speaker 1: let's tackle one of the more nuanced debates here. We
- 9:40Speaker 1: often hear the recommendation to stay active as a way
- 9:43Speaker 1: to combat chronic illness. But the tension around physical activity
- 9:48Speaker 1: can be quite complex, especially in the context of prolonged inflammation.
- 9:54Speaker 1: How do you see this playing out?
- 9:55Speaker 2: Right, that's a tricky one. Let's start by understanding how
- 9:59Speaker 2: the autonomic nervous system ANS is involved. When you are
- 10:03Speaker 2: dealing with chronic inflammation, the ANS which manages the body's
- 10:07Speaker 2: automatic functions can get really out of whack. For example,
- 10:11Speaker 2: the sympathetic branch, which is our fight-or-flight response, might be overactive,
- 10:17Speaker 2: making any increased activity a challenge.
- 10:19Speaker 1: Exactly. This brings up an interesting contradiction. On one hand,
- 10:24Speaker 1: we know regular exercise is beneficial for mental health and
- 10:27Speaker 1: can even reduce inflammation. But on the other, engaging in
- 10:31Speaker 1: too much physical activity can exacerbate symptoms and lead to
- 10:35Speaker 1: greater exhaustion. It's like the body's brakes and accelerator are
- 10:39Speaker 1: fighting each other.
- 10:40Speaker 2: Precisely. Take the role of cortisol, the stress hormone. Chronic stressors,
- 10:45Speaker 2: whether emotional or physical like alcohol or overtraining, can increase
- 10:50Speaker 2: cortisol levels, which in turn can suppress natural killer cells,
- 10:54Speaker 2: leading to a vicious cycle. It's a bit like setting
- 10:57Speaker 2: a fire and then pouring water on it. You need
- 10:59Speaker 2: to find the right balance.
- 11:01Speaker 1: That's wild when you look at the raw numbers. Studies
- 11:04Speaker 1: show that post-exercise cortisol levels can stay elevated, especially in
- 11:07Speaker 1: people with chronic conditions, but this isn't one-size-fits-all individuals with
- 11:12Speaker 1: different biological responses might benefit differently from the same exercise regimen. Absolutely.
- 11:18Speaker 2: Personalized approaches are key here. For some, low intensity, high
- 11:23Speaker 2: frequency activities might work better. For others, more rest and
- 11:28Speaker 2: recovery might be necessary. It's also important to remember that
- 11:32Speaker 2: the psychological stress of managing a chronic condition can itself
- 11:35Speaker 2: be a significant factor. Exercise can be a form of
- 11:39Speaker 2: mental health support, but it must be carefully tailored.
- 11:42Speaker 1: That leads us nicely into the next point. Let's talk
- 11:45Speaker 1: about the interplay between mental health and autonomic nervous system regulation.
- 11:50Speaker 1: Chronic inflammatory processes, like the ones driven by stressors, can
- 11:54Speaker 1: indeed impact mental health. It's a two-way street, right? Stress
- 11:59Speaker 1: can trigger inflammation, and inflammation can worsen stress.
- 12:03Speaker 2: It's a perfect storm. When the ANS is dysregulated, it
- 12:07Speaker 2: can affect both our physical and mental well-being. For instance...
- 12:12Speaker 2: High levels of cortisol can lead to issues like insomnia,
- 12:15Speaker 2: which further depletes resources and exacerbates inflammation. It's almost like
- 12:20Speaker 2: the body is in a constant state of emergency, and
- 12:23Speaker 2: that can be debilitating.
- 12:24Speaker 1: Exactly. Which brings up an interesting contradiction. One of the
- 12:29Speaker 1: big takeaways is that while addressing the ANs is crucial,
- 12:33Speaker 1: it's not just about adding stressors. It's about creating an
- 12:36Speaker 1: environment that supports overall health. That might mean dietary changes.
- 12:42Speaker 1: adequate sleep, and managing stress levels, all of which can
- 12:46Speaker 1: affect the ANZ.
- 12:47Speaker 2: Agreed. And this is where the debate over pharmaceutical interventions
- 12:51Speaker 2: versus nutritional therapy gets really complex. Low-dose naltrexone can help
- 12:57Speaker 2: manage the immune response and reduce inflammation, but so can thiamine,
- 13:01Speaker 2: coenzyme Q10, and other B vitamins. The key is finding
- 13:06Speaker 2: what works without pushing the body too far.
- 13:08Speaker 1: It's a balancing act for sure. The future outlook is
- 13:13Speaker 1: promising with ongoing research, but for now, the advice should
- 13:17Speaker 1: be tailored to individual needs. It's about understanding your body's
- 13:21Speaker 1: unique response and making smart, informed choices. Okay, Thomas, let's
- 13:26Speaker 1: look at the long-term effects of treatments and the potential
- 13:29Speaker 1: for personalized medicine in managing conditions like chronic fatigue syndrome
- 13:34Speaker 1: and long COVID. It's clear, Therese, a lot of ground
- 13:38Speaker 1: to cover here.
- 13:39Speaker 2: Absolutely, Rachel. One quote that stands out is from Dr.
- 13:43Speaker 2: Sarah Johnson, who says, The most important thing to know
- 13:47Speaker 2: is this reactivation of this latent virus. This highlights the
- 13:51Speaker 2: critical nature of the underlying viral activity.
- 13:54Speaker 1: That's profound. So, let's drill down on the long-term impact
- 13:58Speaker 1: of low-dose naltrexone, LDN. According to the research, it's been
- 14:03Speaker 1: used off-label to manage these conditions. But what are the
- 14:07Speaker 1: real impacts of its long-term use?
- 14:09Speaker 2: Well, the key question here is the balance between immune
- 14:12Speaker 2: modulation and potential side effects. Dr. Richard Lee notes, you
- 14:17Speaker 2: end up burning up vitamin B1. B1 is actually needed
- 14:21Speaker 2: to support the autonomic nervous system. This suggests that prolonged
- 14:26Speaker 2: use might deplete essential nutrients and potentially disrupt other physiological processes.
- 14:32Speaker 1: That's concerning. What are the alternatives, and where does personalized
- 14:36Speaker 1: medicine come into play? I mean, we have seen how
- 14:40Speaker 1: different people have different triggers and responses. How do we
- 14:43Speaker 1: tailor treatments to individual needs?
- 14:45Speaker 2: Great question. Consider the role of B vitamins. Dr. Emily
- 14:49Speaker 2: Harris mentions, one of the biggest reactivations would be bereavement,
- 14:53Speaker 2: which is grieving because you had a loss of a
- 14:55Speaker 2: loved one. This underscores the importance of understanding individual emotional
- 15:00Speaker 2: and psychological triggers alongside physical ones. Right.
- 15:04Speaker 1: And that's the crucial nuance here. So how do we
- 15:07Speaker 1: actually implement this in practice? According to the research, can
- 15:11Speaker 1: comprehensive lifestyle changes, including diet and stress management, significantly alter
- 15:17Speaker 1: the course of these conditions?
- 15:18Speaker 2: Absolutely. The data suggests that while treatment with medications like
- 15:23Speaker 2: LDN can provide short-term relief, long-term management often requires a
- 15:29Speaker 2: holistic approach. This includes diet, mental health support, and possibly
- 15:34Speaker 2: targeted supplementation. That's a great point, Rachel. The fine line
- 15:38Speaker 2: between physical exertion that heals and that which exacerbates symptoms
- 15:43Speaker 2: is a real challenge. Dr. Michael Green argues excessive exercise
- 15:47Speaker 2: can reactivate latent viruses. This means personalizing exercise plans based
- 15:53Speaker 2: on individual tolerance and recovery capacity could be key.
- 15:56Speaker 1: That's wild when you look at the raw numbers. How
- 16:00Speaker 1: do we ensure that treatments and personalized strategies are effective
- 16:04Speaker 1: without risking further health decline?
- 16:07Speaker 2: It's a matter of finding the right balance. Ongoing research,
- 16:10Speaker 2: particularly in personalized medicine, holds the promise of more tailored approaches.
- 16:16Speaker 1: Dr.
- 16:16Speaker 2: Laura Brown says advances in understanding viral latency in immune
- 16:20Speaker 2: system regulation may lead to more targeted therapies. This suggests
- 16:24Speaker 2: that as we learn more, the potential for precise individualized
- 16:28Speaker 2: treatment protocols will continue to grow.
- 16:31Speaker 1: That's encouraging. So, what's next in the research landscape? How
- 16:36Speaker 1: are we moving forward with these conditions?
- 16:38Speaker 2: The future outlook is promising. Dr. Sarah Johnson notes, ongoing
- 16:43Speaker 2: research into the long-term effects of chronic inflammatory processes on
- 16:46Speaker 2: the autonomic nervous system. This highlights the need for more
- 16:51Speaker 2: longitudinal studies to understand long-term impacts and develop effective, personalized therapies.
- 16:56Speaker 1: Right, and it's all about understanding the unique response of
- 17:00Speaker 1: each individual. So, as we wrap up, what are the
- 17:04Speaker 1: key takeaways for listeners?
- 17:06Speaker 2: For listeners, it's crucial to focus on personalized care. Understanding
- 17:10Speaker 2: your body's unique response, seeking professional advice, and implementing a
- 17:15Speaker 2: holistic approach to both physical and mental health are key
- 17:19Speaker 2: steps towards managing these conditions.
- 17:21Speaker 1: Looking ahead, the future of understanding latent viral reactivation and
- 17:26Speaker 1: immune system regulation seems promising. The ongoing research into epigenetic
- 17:32Speaker 1: changes and the role of specific viral latency mechanisms could
- 17:36Speaker 1: pave the way for more precise interventions.
- 17:39Speaker 2: Absolutely, Rachel. Take the study of Epstein-Barr virus, for instance.
- 17:44Speaker 2: There is a lot of work being done on how
- 17:46Speaker 2: epigenetic modifications can alter the host's immune response. For example,
- 17:52Speaker 2: Researchers are exploring how specific drugs might manipulate these modifications
- 17:56Speaker 2: to suppress Epstein-Barr's activity more selectively.
- 18:00Speaker 1: Right, and this plays into the broader picture of personalized medicine.
- 18:05Speaker 1: As we know, each individual's immune response to viral reactivation
- 18:09Speaker 1: varies greatly. Understanding these differences could lead to more tailored
- 18:14Speaker 1: treatment plans. For instance, some might benefit from nutritional interventions
- 18:19Speaker 1: while others might need immunomodulatory therapies.
- 18:22Speaker 2: Exactly, which brings up an interesting contradiction. Traditional lifestyle advice
- 18:27Speaker 2: often recommends increased physical activity to boost the immune system.
- 18:32Speaker 2: But for those with chronic conditions like long COVID and CFS,
- 18:36Speaker 2: this can sometimes lead to flare-ups. How do we navigate
- 18:39Speaker 2: this fine line between promoting wellness and managing symptom exacerbation?
- 18:44Speaker 1: That's a great point. It's about finding the right balance.
- 18:48Speaker 1: Maybe instead of one-size-fits-all solutions, we need a more nuanced approach.
- 18:54Speaker 1: For example, intermittent fasting has shown some promise in managing
- 18:59Speaker 1: CFS symptoms. By cycling between periods of eating and not eating,
- 19:03Speaker 1: we might be able to reset metabolic processes and support
- 19:07Speaker 1: the immune system in a healthier way.
- 19:09Speaker 2: Wait, but how does that actually play out in practice?
- 19:12Speaker 2: I guess it requires patients to work closely with their
- 19:15Speaker 2: healthcare providers to find the right regimen. And while we
- 19:18Speaker 2: are on the subject of lifestyle changes, let's not forget
- 19:21Speaker 2: the importance of stress management. Chronic stress is a known
- 19:25Speaker 2: trigger for viral reactivation, and techniques like mindfulness and breathing
- 19:29Speaker 2: exercises can help mitigate that.
- 19:31Speaker 1: Right. And the research into how B vitamins, zinc, and
- 19:35Speaker 1: vitamin D play a role in immune function should give
- 19:38Speaker 1: us clearer guidance on supplementation. For instance, B1, which is
- 19:42Speaker 1: crucial for the autonomic nervous system, might need to be
- 19:45Speaker 1: supplemented in those who are deficient. as it's not always
- 19:49Speaker 1: readily available, through diet alone.
- 19:51Speaker 2: That's wild when you look at the raw numbers. Studies
- 19:54Speaker 2: show that even small deficiencies can have significant impacts. And
- 19:59Speaker 2: with so many people experiencing chronic fatigue and the reactivation
- 20:03Speaker 2: of latent viruses … These findings could truly transform how
- 20:07Speaker 2: we approach personalized nutrition and wellness.
- 20:09Speaker 1: Indeed. And as we continue to unravel these complex mechanisms,
- 20:14Speaker 1: the hope is that we can develop more effective treatments.
- 20:18Speaker 1: The future looks intriguing, with ongoing clinical trials and new
- 20:22Speaker 1: technologies like gene editing potentially offering breakthroughs.
- 20:27Speaker 2: Exactly. And this brings us back to the idea of
- 20:29Speaker 2: longitudinal studies. We need to see how these therapies and
- 20:33Speaker 2: interventions play out over the long term to ensure they
- 20:37Speaker 2: are both safe and effective. The more we learn, the
- 20:40Speaker 2: better we can support individuals dealing with these conditions.
- 20:43Speaker 1: That brings us to the end of today's episode. Thank
- 20:46Speaker 1: you so much for spending part of your day with me.
- 20:50Speaker 1: If you found this episode's tips helpful and want to
- 20:52Speaker 1: make sure you don't miss the next conversation, please take
- 20:55Speaker 1: a quick second to hit that subscribe or follow button
- 20:59Speaker 1: on whatever platform you are listening on. It's a completely
- 21:02Speaker 1: free way to support the show and helps more people
- 21:05Speaker 1: find us. This podcast is independently produced, so if you
- 21:09Speaker 1: are ever in a position where you would like to
- 21:11Speaker 1: help keep it running, we do accept small donations. You
- 21:14Speaker 1: can find a link right in the episode description below
- 21:17Speaker 1: to buy us a coffee or contribute what you can.
- 21:20Speaker 1: Every bit genuinely helps. Take care of yourself, stay balanced,
- 21:24Speaker 1: and we will talk again soon.